The treatment of animal models of malaria with iron chelators by use of a novel polymeric device for slow drug release

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 3, 1997, Pages 1127-1135

  Golenser, Jacob ^a,d   Domb, Abraham ^a   Teomim, Doron ^a   Tsafack, Appolinaire ^a   Nisim, Orna ^a   Ponka, Prem ^b   Eling, Wijnand ^c   Cabantchik, Z Ioav ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b MCGILL UNIVERSITY   (Canada)

^c RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^d HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CHELATING AGENT; DEFEROXAMINE MESYLATE; DRUG VEHICLE; ISONIAZID DERIVATIVE; POLYMER; SALICYLALDEHYDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMALARIAL ACTIVITY; ARTICLE; BLOOD SMEAR; BRAIN MALARIA; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG IMPLANT; DRUG POTENCY; DRUG POTENTIATION; FEMALE; HYDROPHILICITY; INTRAPERITONEAL DRUG ADMINISTRATION; IRON CHELATION; IRON OVERLOAD; LIPOPHILICITY; MALARIA; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PLASMODIUM VINCKEI; PRIORITY JOURNAL; SLOW DRUG RELEASE; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; FEMALE; IRON CHELATING AGENTS; MALARIA; MALE; MICE; MICE, INBRED C57BL; TIME FACTORS;

EID: 0030946105     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. BAKER, E., RICHARDSON, D. R., GROSS, S. AND PONKA, P.: Evaluation of the iron chelation potential of pyridoxal, salicylaldehyde and 2-hydroxy-1-naphthylaldehyde using the hepatocyte in culture. Hepatology 15: 492-501, 1992.
2. BUNNAG, D., POLTERA, A. A., VIRAVAN, C., LOOAREESUWAN, S., HARINASUTA, K. T. AND SCHINDLERY, C.: Plasmocidal effect of DFO in human vivax or falciparum malaria from Thailand. Acta Trop. 52: 59-67, 1992.
3. CABANTCHIK, Z. I.: The mode of action of iron (III) chelators as anti malarials. The biochemical basis of selective cytotoxicity. Parasitol. Today. 11: 74-78, 1994.
4. CABANTCHIK, Z. I., GLICKSTEIN, H., GOLENSER, J., LOYEVSKY, M. AND TSAFACK, A.: Iron chelators: Mode of action as antimalarials. Acta Haematol. 95: 70-77, 1996.
5. CHASIN, M., DOMB, A. J., RON, E., MATHIOWITZ, K., LEONG., K., LAURENCIN, H., BREM, H. AND LANGER, R.: Polyanhydrids as drug delivery systems. In Degradable Polymers as Drug Delivery Systems, ed. by R. Langer and M. Chasin, pp. 43-71, Marcel Dekker, New York, NY, 1990.
6. CURFS, J., SCHERRERS, T., HERMSEN, C., JERUSALEM, C., VAN ZON, A. AND ELING, W.: Immunological aspects of cerebral lesions in murine malaria. Clin. Exp. Immunol. 75: 136-140, 1989.
7. DOMB A. J.: Implantable biodegradable polymers for site specific drug delivery. In Polymeric Site-Specific Pharmacotherapy, ed. by A. J. Domb, pp. 1-26, Wiley, Chichester, England, 1994.
8. DOMB, A. J., AMSELEM, S., LANGER, R. AND MANIAR, M.: Polyanhydrids as carriers of drugs. In: Designed to Degrade Biomedical Polymers, ed. by S. Shalaby, pp 69-96, Carl Hauser Verlag, 1993.
9. DOMB A. J. AND MANIAR, M.: Absorbable biopolymers derived from dimer fatty acids. J. Polym. Sci. 31: 1275-1285, 1993.
10. DOMB, A. J., ROCK, M., PERKIN, C., YIPCHUCK, G., BROXAP, B. AND VILLEMURE, J. G.: Excretion of a radiolabelled anticancer biodegradable polymeric implant from the rabbit brain. Biomaterials 16: 319-323, 1995.
11. ELING, W. M. C. AND SAUERWEIN, R. W.: Severe and cerebral malaria: Common or distinct pathophysiology? Rev. Med. Microbiol. 5: 1-9, 1995.
12. 14C-DFO: Uptake into erythrocytes infected with P. falciparum. Z. Parasitenkd. 72: 709-713, 1986.
13. GOLENSER, J. AND CHEVION, M.: Implications of oxidant stress and malaria. In Tropical Medicine, Implications of Oxygen Free Radicals, ed. by O. I. Aruoma, pp. 53-79, Harwood Academic Publishers, Chur, Switzerland, 1994.
14. GOLENSER, J., TSAFACK, A., LIBMAN, J., SHANZER, A. AND CABANTCHIK, Z. I.: The antimalarial action of hydroxamate-based iron chelators. Effects of drug combinations. Antimicrob. Agents Chemother. 39: 61-69, 1995.
15. GORDEUK, V. R., BRITTENHAM, G. M. AND THUMA, P. E.: Iron chelation as a chemotherapeutic strategy in the treatment of malaria. In The Development of Iron Chelators for Clinical Use, ed. by R. J. Bergeron and G. M. Brittenham, pp. 111-130, CRC Press Inc., Boca Raton, FL, 1994.
16. GORDEUK, V. R., THUMA, P. E. AND BRITTENHAM, G. M.: Iron chelation therapy in malaria. In Progress in Iron Research, ed. by C. Hershko, pp. 371-383, Plenum Press, New York, 1994.
17. GORDEUK, V. R., THUMA, P. E., BRITTENHAM, G. M., BIEMBA, G., ZULU, S., SIMWANZA, G., KALENSE, P., M'HANGO, A., PARRY, D., POLTERA, A. A. AND AIKAWA, M.: Iron chelation as a chemotherapeutic strategy for falciparum malaria. Am. J. Trop. Med. Hyg. 48: 193-197, 1993.
18. GRAU, G. E., PIGUET, P. F., ENGERS, H. D., LOUIS, J. A., VASSALLI, P. AND LAMBERT, P. H.: L3T4+ T lymphocytes play a major role in the pathogenesis of murine cerebral malaria. J. Immunol. 137: 2348-2354, 1986.
19. HERSHKO, C., IHEANACHO, E. N., SPIRA, D. T., PETER, H. H., DOBBIN, P. AND HIDER, R. C.: The effect of N-alkyl modification on the antimalarial activity of 3-hydroxypyridin-4-one oral iron chelators. Blood 77: 637-643, 1991.
20. HUNT, A. N., KOPP, M. AND STOCKER, R.: Free radicals and antioxidants in malaria. In: Lipid Soluble Antioxidants: Biochemistry and Clinical Application, ed. by O. N. G. Ash and L. Packer, pp. 337-354, Birkhouser Verlag, Basel, Switzerland, 1992.
21. KAUL, D. K., NAGEL, R. L., LLENA, J. F. AND SHEAR, H. L.: Cerebral malaria in mice: demonstration of cytoadherence of infected red blood cells and microrheologic correlates. Am. J. Trop. Med. Hyg. 50: 512-521, 1994.
22. LOYEVSKY, M., LYTTON, S. D., MESTER, B., LIBMAN, J., SHANZER, A. AND CABANTCHIK, Z. I.: The antimalarial action of Desferal involves a direct access route to erythrocytic parasites (P. falciparum). J. Clin. Invest. 91: 218-224, 1993.
23. LYTTON S. D., MESTER, B., LIBMAN, J., SHANZER, A. AND CABANTCHIK, Z. I.: Mode of action of iron (III) chelators as antimalarials: II. Evidence for differential effects on parasite iron-dependent nucleic acid synthesis. Blood. 84: 910-915, 1994.
24. MABEZA, G. E., BIEMBA, G. AND GORDEUK, V. R.: Clinical studies of iron chelators in malaria. Acta Haematol. 95: 78-86, 1996.
25. MACPHERSON, G. G., WARRELL, M. J. AND WHITE, N. J.: Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am. J. Pathol. 119: 385-401, 1985.
26. OLIVIERI, N. F., BRITTENHAM, G. M., MATSUI, D., BERKOVITCH, M. AND OTHERS. IRON-CHELATION THERAPY WITH ORAL DEFERIPRONEIN PATIENTS WITH THALASSEMIA MAJOR N. ENGL. J. MED. 332: 918-922, 1995.
27. PETERS, W.: Drug resistance in malaria. Recent Progr. Med. 81: 749-753, 1990.
28. POLDER, T., ELING, W., CURFS, J., JERUSALEM, C. AND WIJERS-ROUW, M.: Ultra-structural changes in the blood brain barrier of mice infected with P. berghei. Acta Leiden. 60: 31-46, 1992.
29. PORTER, J. B.: Evaluation of new iron chelators for clinical use. Acta Haematol. 95: 13-25, 1996.
30. SCHWARZER, E., TURRINI, F., ULLIERS, D., GIRIBALDI, G., GINSBURG, H. AND ARESE, P.: Impairment of macrophage functions after ingestion of Plasmodium falciparum infected erythrocytes or isolated malarial parasites. J. Exp. Med. 176: 1033-1041, 1992.
31. SCOTT, M. D., RANZ, A., KUYPERS, F. A., LUBIN, B. H. AND MESHNICK, S. R.: Parasite uptake of deferoxamine: a prerequisite for antimalarial activity. Br. J. Haematol. 75: 598-602, 1990.
32. TANNER, M. AND EVANS, D.: Vaccines or drugs: Complementarity is crucial. Parasitol. Today 10: 406-407, 1994.
33. THUMA, T. E., WEISS, G., HEROLD, M. AND GORDEUK, V. R.: Serum neopterin, interleukin 4 and interleukin 6 concentrations in cerebral malaria patients and the effect of iron chelation therapy. Am. J. Trop. Med. Hyg. 54: 164-168, 1996.
34. TSAFACK, A., GOLENSER, J., LIBMAN, J., SHANZER, A. AND CABANTCHIK Z. I.: Mode of action of iron (III) chelators as antimalarials. III. Overadditive effects in the combined action of hydroxamate-based agents on in vitro growth of P. falciparum. Mol. Pharmacol. 47: 403-409. 1995.
35. TSAFACK, A., GOLENSER, J., LIBMAN, J., SHANZER, A. AND CABANTCHIK, Z. I.: Chemical determinants of iron chelators as antimalarials. Antimicrob. Agents Chemother., in press, 1996a.
36. TSAFACK, A., LOYEVSKY, M., PONKA, P. AND CABANTCHIK Z. I.: Mode of action of iron (III) chelators as antimalarials. IV. Potentiation of Desferal action by benzoyl and isonicotinoyl hydrazone derivatives. J. Lab. Clin. Med. 127: 574-582, 1996b.
37. VANDAMME, T. F. AND HELLER, J.: Poly (ortho esters) as bioerodible matrices for the controlled delivery of pyrimethamine in chemoprophylaxis of malaria. J. Controlled Release 36: 209-214, 1995.
38. VENNERSTROM, J. L., W. Y. ELIS, W. K. MILHOUS AND J. W. EATON. ANTIMALARIAL SYNERGISM AND ANTAGONISM. IN SYNERGISM AND ANTAGONISM IN CHEMOTHERAPY, ED. BY T. C. CHOU AND D. C. RIDEOUT, PP.183-222, ACADEMIC PRESS, SAN DIEGO, 1991.
39. WALLACE, M. R., SHARP, T. W., SMOAK B., IRIYE, C., ROZMAJZL, P., THORNTON, S. A., BATCHELOR, R., MAGILL, A. J., LOBEL, H. O., LONGER, C. F. AND BURANS, J. P.: Malaria among US troops in Somalia. Am. J. Med. 100: 49-55, 1996.